Successful Treatment of Chronic Hepatitis D with a Short Course of Peginterferon Alfa-2a
Overview
Affiliations
Mangia A, Squillante M, Fraticelli F, Cavorsi M, Paroni G, Zaffarano L Cells. 2023; 12(10).
PMID: 37408247 PMC: 10217045. DOI: 10.3390/cells12101413.
Jachs M, Panzer M, Hartl L, Schwarz M, Balcar L, Camp J JHEP Rep. 2023; 5(8):100751.
PMID: 37360907 PMC: 10285645. DOI: 10.1016/j.jhepr.2023.100751.
Treatment of Chronic Hepatitis D with Bulevirtide-A Fight against Two Foes-An Update.
Ferenci P, Reiberger T, Jachs M Cells. 2022; 11(22).
PMID: 36428959 PMC: 9688382. DOI: 10.3390/cells11223531.
Targeting the Host for New Therapeutic Perspectives in Hepatitis D.
Turon-Lagot V, Saviano A, Schuster C, Baumert T, Verrier E J Clin Med. 2020; 9(1).
PMID: 31947588 PMC: 7019876. DOI: 10.3390/jcm9010222.
Standard and pegylated interferon therapy of HDV infection: A systematic review and meta- analysis.
Alavian S, Tabatabaei S, Behnava B, Rizzetto M J Res Med Sci. 2013; 17(10):967-74.
PMID: 23825999 PMC: 3698658.